Calluna Pharma AS
Latest round
- Series A
Last raised
- Jan 2024
Total raised
- $82M
Investors
- 4
About Calluna Pharma AS
Based in Oslo, Norway, and founded in 2024, Calluna Pharma AS, formed from the merger of Oxitope Pharma and Arxx Therapeutics, operates as a clinical-stage biotechnology company. The company offers therapeutic solutions to improve patient outcomes in diseases like inflammatory and fibrotic diseases, where existing treatments are sub-optimal. Calluna adopts a therapeutic approach and precision targets upstream innate immune amplifiers developing a pipeline of therapeutic antibodies to restore tissue homeostasis and disrupt disease progression. Spearheading their portfolio is CAL101, a monoclonal antibody designed to neutralize S100A4, offering hope to patients with conditions like idiopathic pulmonary fibrosis, chronic kidney disease, and severe asthma. Other 3 therapies in the pipeline of the firm include CAL102, CAL103, and CAL104 for MI reperfusion injury, chronic pipeline, and chronic indication respectively.
Who invested in Calluna Pharma AS
4 investors across 1 round
See all investors in Calluna Pharma AS
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 23, 2024
Amount
$82M
Investors
Questions about Calluna Pharma AS
Who invested in Calluna Pharma AS?
Calluna Pharma AS has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Calluna Pharma AS raised?
Calluna Pharma AS has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Calluna Pharma AS last raise money?
Calluna Pharma AS's most recent round on record is a Series A, in Jan 2024.
What does Calluna Pharma AS do?
Based in Oslo, Norway, and founded in 2024, Calluna Pharma AS, formed from the merger of Oxitope Pharma and Arxx Therapeutics, operates as a clinical-stage biotechnology company.
Where is Calluna Pharma AS headquartered?
Calluna Pharma AS is headquartered in Oslo, Norway.
Which VCs invest in companies like Calluna Pharma AS?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Calluna Pharma AS's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Calluna Pharma AS? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.